Skip to main content

SOP

Cerebrospinal Fluid (CSF) Culture

Specimen-specific culture workflow for cerebrospinal fluid (csf) culture using validated microbiological methods.

Last verified 1 month ago 2 min read Microbiology Clinical Bacteriology #CSF Culture #Meningitis #Sterile Site Culture
Link copied!
Document Control
Version
1.0
Effective
Aug 31, 2026
Reviewed
Aug 28, 2026
Department
Microbiology
Principle

Because CSF is a critical normally sterile-site specimen, prompt processing and appropriate culture methods are essential for recovery of clinically significant organisms.

Purpose

To standardize processing and culture of cerebrospinal fluid (csf) culture.

Scope

This procedure applies to trained microbiology laboratory personnel working within an approved quality-management and biosafety system.

Principle

Because CSF is a critical normally sterile-site specimen, prompt processing and appropriate culture methods are essential for recovery of clinically significant organisms.

Specimen / Test Material

Cerebrospinal fluid collected aseptically into an approved sterile container.

Equipment and Materials

  • Appropriate validated culture media
  • Inoculating equipment
  • Incubation system
  • Identification reagents or system
  • AST materials where indicated

Procedure

  1. Treat the specimen as urgent according to laboratory policy.
  2. Verify identification and specimen integrity.
  3. Process promptly using the validated CSF workflow.
  4. Perform appropriate microscopy and culture.
  5. Incubate and investigate significant growth.
  6. Communicate critical findings according to the laboratory escalation policy.

Quality Control and Quality Assurance

Prioritize rapid processing; monitor media, microscopy and critical-result communication.

Reporting

Report clinically significant findings, relevant negative results and limitations according to laboratory policy.

Safety

Use risk-based biosafety practices, appropriate personal protective equipment and approved decontamination and waste-disposal procedures. Treat clinical specimens and cultures according to the laboratory's biological risk assessment.

References

  • World Health Organization (WHO): Toolkit for Standard Operating Procedures for Bacteriology, Mycology and Antimicrobial Susceptibility Testing.
  • WHO: Laboratory Biosafety Manual, 4th edition.
  • WHO guidance on collection, packaging and transport of infectious substances.
  • EUCAST methodology and quality-control guidance for antimicrobial susceptibility testing, where applicable.
  • Current locally approved laboratory procedures and validated manufacturer instructions.

Frequently Asked Questions

Poor collection or transport can reduce recovery of clinically significant organisms or increase contamination.
No. Significance depends on specimen source, organism, quantity and clinical context.